X vivo gene therapy

GENETIC2 trials

Sponsors

Genethon

Conditions

X-Linked Chronic Granulomatous Disease

Phase 1

Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)

TerminatedNCT01855685

GenethonX-Linked Chronic Granulomatous Disease

Start: 2013-06-24End: 2025-10-17Updated: 2026-04-13

Gene Therapy for X-linked Chronic Granulomatous Disease

TerminatedNCT02757911

GenethonX-Linked Chronic Granulomatous Disease

Start: 2013-06-24End: 2025-10-17Updated: 2026-04-13

Related Papers

Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy

Cell Reports Medicine2023-01-2626 citations

Lentiviral gene therapy for X-linked chronic granulomatous disease

Nature Medicine2020-01-27242 citations